Type 2 Diabetes Mellitus
📧 Sign up to get email alerts when something new happens for Type 2 Diabetes Mellitus.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-01-03Clinical Trial Update: Efficacy and Safety of Jinshuibao Capsule on Diabetic Kidney Disease [Phase 2, Phase 3]
Phase 2/3 clinical trial evaluating the efficacy and safety of Jinshuibao Capsule for diabetic kidney disease in Type 2 diabetes patients ha…
-
CLINICAL_TRIALS trial_result · 2024-01-03Clinical Trial Update: A Study of the Efficacy and Safety of Semaglutide Injection in the Treatment of Type 2 Diabetes Mellitus [Phase 3]
Phase 3 trial evaluating the efficacy and safety of semaglutide injection for type 2 diabetes has completed.
-
CLINICAL_TRIALS trial_result · 2024-01-02Clinical Trial Update: Effect of Insulin Detemir on Blood Glucose Control in Subjects With Type 2 Diabetes [Phase 3]
Phase 3 trial update evaluating insulin detemir on blood glucose control in adults with type 2 diabetes.
-
CLINICAL_TRIALS trial_result · 2023-12-29Clinical Trial Update: FLuctuATion Reduction With inSULin and Glp-1 Added togetheR (FLAT-SUGAR) [Phase 4]
Phase 4 clinical trial update on combining insulin and GLP-1 agonist to reduce fluctuations in Type 2 diabetes; results posted after complet…
-
CLINICAL_TRIALS trial_result · 2023-12-29Clinical Trial Update: Effects of SGLT-2 Inhibition on Myocardial Fibrosis and Inflammation as Assessed by Cardiac MRI in Patients With DM2 [Phase 4]
Phase 4 trial evaluating the effects of SGLT-2 inhibition on myocardial fibrosis and inflammation in type 2 diabetes patients using cardiac …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-12-29Clinical Trial Update: TEEN HEED: An Adolescent Diabetes Prevention Intervention Incorporating Novel Mobile Health Technologies [NA]
A completed adolescent diabetes prevention trial (TEEN HEED) evaluating a mobile health technology–based intervention for type 2 diabetes pr…
-
FDA approval · 2023-12-28FDA Approved: JANUVIA — Supplemental Application (Merck Sharp & Dohme LLC)
The FDA approved a supplemental application for Januvia (sitagliptin) filed by Merck Sharp & Dohme LLC.
-
CLINICAL_TRIALS trial_result · 2023-12-28Clinical Trial Update: Metabolic Effects of Hydroxychloroquine [NA]
A terminated clinical trial investigating the metabolic effects of hydroxychloroquine in Type 2 diabetes mellitus with results posted.
-
CLINICAL_TRIALS trial_result · 2023-12-27Clinical Trial Update: A Study of IBI362 in Chinese Patients With Type 2 Diabetes [Phase 2]
Phase 2 clinical trial update for IBI362 in Chinese patients with Type 2 Diabetes has completed.
-
CLINICAL_TRIALS trial_result · 2023-12-26Clinical Trial Update: Endogenous GLP-1 Secretion on Islet Function in People With and Without Type 2 Diabetes [Phase 3]
Phase 3 clinical trial examining endogenous GLP-1 secretion and its effect on islet function in healthy individuals and those with Type 2 di…
-
CLINICAL_TRIALS trial_result · 2023-12-20Clinical Trial Update: Effect of Exercise and/or Liraglutide on Vascular Dysfunction and Insulin Sensitivity in Type 2 Diabetes ( ZQL007) [Phase 4]
Phase 4 trial update evaluating exercise and/or liraglutide on vascular dysfunction and insulin sensitivity in type 2 diabetes.
-
CLINICAL_TRIALS research · 2023-12-18Clinical Trial Update: Effect of High Carbohydrate vs. Low Carbohydrate Diet in Type 2 Diabetes [NA]
A completed clinical trial comparing high carbohydrate versus low carbohydrate diets in adults with type 2 diabetes; results posted in 2023.
-
CLINICAL_TRIALS trial_result · 2023-12-15Clinical Trial Update: A Study to Test How Well Empagliflozin Works in Chinese Patients With Type 2 Diabetes Who Already Take Insulin [Phase 3]
A Phase 3 trial evaluating the efficacy of empagliflozin in Chinese patients with type 2 diabetes who are already on insulin, completed with…
-
CLINICAL_TRIALS trial_result · 2023-12-15Clinical Trial Update: Effects of Degludec/Liraglutide on Time in Range, Inflammation and Endothelial Function vs Insulin Basal Bolus in Diabetic Inpatients [Phase 4]
Phase 4 trial comparing degludec/liraglutide versus insulin basal bolus in type 2 diabetes inpatients, focusing on time in range, inflammati…
-
CLINICAL_TRIALS trial_result · 2023-12-13Clinical Trial Update: Evaluating Metabolic Mechanisms of Ertugliflozin in Diabetes & Heart Failure [Phase 4]
Phase 4 clinical trial evaluating metabolic mechanisms of ertugliflozin in patients with diastolic heart failure and type 2 diabetes was ter…
-
CLINICAL_TRIALS trial_result · 2023-12-13Clinical Trial Update: CTSI Pilot: Improving Adherence to Diabetic Diet [NA]
A completed pilot clinical trial focused on improving adherence to a diabetic diet for individuals with type 2 diabetes, with results posted…
-
CLINICAL_TRIALS trial_result · 2023-12-12Clinical Trial Update: Simplified Insulin Regimen for the Elderly [Phase 4]
Phase 4 trial update on a simplified insulin regimen for elderly patients with Type 2 Diabetes Mellitus; study terminated with results poste…
-
CLINICAL_TRIALS trial_result · 2023-12-11Clinical Trial Update: Exogenous Ketones in Type 2 Diabetes [NA]
A clinical trial investigating exogenous ketones in people with Type 2 diabetes has completed, with results posted.
-
CLINICAL_TRIALS trial_result · 2023-12-08Clinical Trial Update: COMRADE: Collaborative Care Management for Distress and Depression in Rural Diabetes [NA]
Completed clinical trial evaluating collaborative care management for distress and depression in rural diabetes patients; results posted.
-
CLINICAL_TRIALS trial_result · 2023-12-01Clinical Trial Update: DIA_CENTRAL:T2D Treatment Pattern in Central Europe
A completed clinical trial in Central Europe evaluating treatment patterns for type 2 diabetes mellitus.
-
CLINICAL_TRIALS trial_result · 2023-11-30Clinical Trial Update: Effect of Farxiga on Renal Function and Size in Type 2 Diabetic Patients With Hyperfiltration [Phase 4]
Phase 4 trial evaluating the effect of Farxiga on renal function and kidney size in adults with type 2 diabetes and hyperfiltration.
-
FDA approval · 2023-11-29FDA Approved: INSULIN GLARGINE — Supplemental Application (Biocon Biologics Inc.)
FDA approved Biocon Biologics' supplemental application for INSULIN GLARGINE-YFGN (insulin glargine).
-
CLINICAL_TRIALS trial_result · 2023-11-22Clinical Trial Update: Evaluation of Efficacy and Safety When Administered JP-2266 in Type 2 Diabetes Patients [Phase 2]
Phase 2 trial evaluating efficacy and safety of JP-2266 in patients with Type 2 Diabetes Mellitus.
-
CLINICAL_TRIALS trial_result · 2023-11-22Clinical Trial Update: A Trial to Investigate the Efficacy and Safety of NW Low-Glu® in Patients With Type II Diabetes Mellitus [Phase 3]
Phase 3 trial update evaluating NW Low-Glu® for efficacy and safety in adults with Type 2 diabetes mellitus.
-
CLINICAL_TRIALS trial_result · 2023-11-22Clinical Trial Update: Clinical Study Evaluating the Safety and Efficacy of Roflumilast in Type 2 Diabetic Patients With Diabetic Neuropathy [Phase 3]
Clinical trial evaluating safety and efficacy of roflumilast in adults with type 2 diabetes and diabetic neuropathy has completed Phase 3.